相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature
Sigal Tavor et al.
HAEMATOLOGICA (2020)
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial
Eytan M. Stein et al.
LANCET HAEMATOLOGY (2020)
Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor
Beenu Thakral et al.
LEUKEMIA & LYMPHOMA (2020)
Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatment
Meera Yogarajah et al.
LEUKEMIA & LYMPHOMA (2018)
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome
Habibe Kurt et al.
MODERN PATHOLOGY (2018)
Characteristics and Outcomes of Older Patients With Secondary Acute Myeloid Leukemia According to Treatment Approach
Prajwal Chaitanya Boddu et al.
CANCER (2017)
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein et al.
BLOOD (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations
Ulrike Bacher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
分享论文
